Boehringer Ingelheim and Synaffix B.V. (“Synaffix”), a Lonza company (SWX:LONN) focused on commercializing its clinical-stage platform technology for the development of best-in-class antibody-drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback